|
Zosurabalpin |
|
Acinetobacter |
LPS |
Phase I trial |
Pahil KS, et al. 2024. Nature; Que W, et al. 2024. Trends Mol Med |
|
N-(2-{(2Z)-2-[1-(1,3-benzodioxol-5-ylmethyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]hydrazinyl}-2-oxoethyl)pyridine-3-carboxamide |
Depiction based on curated SMILES
O
N
O
N
H
O
O
N
N
H
N
O
|
Acinetobacter |
Regulation |
Preclinical (in vivo) |
Trebosc V, et al. 2022. Virulence |
|
N-[3-(2-amino-1H-imidazol-5-yl)propyl]-1-benzyl-4,5-dibromopyrrole-2-carboxamide;hydrochloride |
Depiction based on curated SMILES
Br
ClH
NH
2
HN
N
HN
O
Br
N
|
Acinetobacter |
Biofilm |
Preclinical (in vitro) |
Richards JJ, et al. 2008. Bioorg Med Chem Lett |
|
N-[3-(2-amino-1H-imidazol-5-yl)propyl]-4,5-dibromo-1-(2-phenylethyl)pyrrole-2-carboxamide;hydrochloride |
Depiction based on curated SMILES
Br
ClH
NH
2
N
H
N
HN
O
Br
N
|
Acinetobacter |
Biofilm |
Preclinical (in vitro) |
Richards JJ, et al. 2008. Bioorg Med Chem Lett |
|
N-[3-(2-amino-1H-imidazol-5-yl)propyl]-4,5-dibromo-1-cyclopentylpyrrole-2-carboxamide;hydrochloride |
Depiction based on curated SMILES
ClH
NH
2
N
H
N
N
H
O
Br
Br
N
|
Acinetobacter |
Biofilm |
Preclinical (in vitro) |
Richards JJ, et al. 2008. Bioorg Med Chem Lett |
|
N-[3-(2-amino-1H-imidazol-5-yl)propyl]-4,5-dibromo-1-ethylpyrrole-2-carboxamide;hydrochloride |
Depiction based on curated SMILES
NH
ClH
H
2
N
NH
N
H
3
C
O
Br
Br
N
|
Acinetobacter |
Biofilm |
Preclinical (in vitro) |
Richards JJ, et al. 2008. Bioorg Med Chem Lett |
|
5beta,6alpha-Bis[4-[(4,5-dibromo-1H-pyrrole-2-yl)carbonylaminomethyl]-1H-1,2,3-triazole-1-ylmethyl]-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
N
H
N
NH
O
N
Br
Br
N
H
N
N
N
H
N
H
N
NH
2
N
H
O
Br
Br
HN
|
Acinetobacter Staphylococcus |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
ZINC Lactate |
Depiction based on curated SMILES
CH
3
O
_
O
HO
CH
3
O
_
O
HO
2+
Zn
|
Acinetobacter |
PNAG |
Preclinical (in vitro) |
Peng Q, et al. 2020. Sci Rep |
|
| | |
| | |
| | |
| | |
| | |